Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

p>

achieved.

Financial Highlights

Net sales of Vancocin(R) were $47.7 million for the fourth quarter of 2007 and $203.8 million for the twelve months of 2007 as compared to $38.5 million and $166.6 million in the respective 2006 periods.

Investment in our product pipeline and the Company continued to grow as research and development (R&D) and marketing, general and administrative (MG&A) expenses were $25.2 million and $72.9 million for the fourth quarter and twelve months of 2007, respectively compared to $10.2 million and $43.7 million for the fourth quarter and twelve months of 2006, respectively. These increases were due primarily to our two phase three studies for Camvia and increased personnel to support our clinical pipeline, along with increased marketing, general and administrative expense due to increases in medical education, share-based compensation and legal and consulting costs.

Operating income in the fourth quarter and twelve months ended December 31, 2007 was $19.0 million and $115.8 million, respectively, compared to $25.1 million and $98.8 million in the fourth quarter and twelve months of 2006, respectively. Operating income in the fourth quarter decreased primarily due to higher R&D and MG&A costs discussed above partially offset by the higher net sales. Operating income for the twelve months of 2007 increased due to higher net sales and lower cost of sales, partially offset by the increase in R&D and MG&A expenses.

"2007 represented a period of strong momentum for ViroPharma - clinical momentum, organizational momentum, and operational momentum - as we continue to be driven by our commitment to bring essential therapies to patients with few, if any, treatment options," commented Michel de Rosen, ViroPharma's chief executive officer. "Our 2007 clinical efforts were primarily driven by Camvia, which was granted Orphan Drug designation in both the U.S. and E.U. and gained global momentum through our pivotal ph
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
10. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
11. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... research from UC San Francisco shows that an ... Project helps women living with HIV disclose their ... and the safety and quality of their relationships., ... first author, Edward L. Machtinger, MD, director of ... percent of our patients are on effective antiretroviral ...
(Date:7/11/2014)... Chino Hills, CA (PRWEB) July 11, 2014 ... camp marketing expert; a title he’s earned by founding the ... fitness professionals on marketing their businesses. He works with successful ... recent blog post on the traits of the most ... top earners share three important qualities. , “I’ve worked with ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 When the mercury ... system. Its driving engine, the heart, takes on a heavier ... reports the July 2014 issue of the Harvard Men's ... the heat requires no more than knowing their limits and ... "They are going to be more sensitive to the heat," ...
(Date:7/11/2014)... As reported by Forbes in the article ... To Blame (6/30), Indino Downey has reportedly been arrested ... smoke it with. His father, well-known actor Robert Downey ... from him may have something to do with his ... the 1980s and 1990s for substance abuse before finally ...
(Date:7/11/2014)... CT (PRWEB) July 11, 2014 Timex, ... today the launch of the Timex Performance Network, the ... information, training plans, athlete testimonials, seasonal news and special ... Network will capitalize on the legacy of the Timex ... destination for runners and endurance athletes nationwide. The hub ...
Breaking Medicine News(10 mins):Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 2Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 3Health News:Roberty Downey's Son Arrested For Cocaine 2Health News:Timex Announces Launch of Timex Performance Network 2
... 2012) An overgrowth of bacteria in the gut has ... of a new Cedars-Sinai study which used cultures from the ... "gold standard" method of connecting bacteria to the cause of ... the United States. Previous studies have indicated that ...
... , THURSDAY, May 24 (HealthDay News) -- Only ... in from tobacco revenues goes to anti-smoking efforts, a new ... Agreement, tobacco companies agreed to reimburse states for Medicaid costs ... new study, the intent of the agreement was to use ...
... filters are often coated with colloidal silver, which prevents ... nano-scale pores of the filter. Other metals such as ... anti-microbial activity. Researchers from Princeton University in New Jersey ... adhesion interaction between Escherichia coli ( E. ...
... (HealthDay News) -- Japanese-American men who don,t eat a diet ... later in life, according to a new, long-term study. ... They were between the ages of 45 and 68 ... and interviewed about their eating habits. During 34 years ...
... how carbohydrates are converted into energy has led to ... a perplexing and potentially fatal neuromuscular disorder and possibly ... the cause of this neuromuscular disorder was unknown. But ... have the disorder, a team led by University of ...
... May 24 (HealthDay News) -- Fatigue is a common problem ... growing body of evidence suggests that fatigue may play a ... the Harvard Orthopaedic Combined Residency Program and Massachusetts General Hospital ... surgery residents who slept an average of 5.3 hours a ...
Cached Medicine News:Health News:Cedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut 2Health News:States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds 2Health News:States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds 3Health News:Pivotal role for proteins -- from helping turn carbs into energy to causing devastating disease 2
(Date:7/10/2014)... 10, 2014   LabStyle Innovations Corp . ... announced the appointment of Professor Richard B. ... Board of Directors. Prof. Stone brings ... to LabStyle as an entrepreneur, venture capitalist public, ... governance expert. He currently serves on the board ...
(Date:1/15/2014)... 2014 Most osteoporosis patients want a choice in ... survey* sponsored by Mission Pharmacal Company. The survey, conducted ... online support community, revealed that 74 percent of osteoporosis ... a form other than a pill or a tablet. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. Designated most popular model or size....
Designated most popular model or size. Double-ended. 2 mm wide....
Desmarres Retractor Size 4...
Medicine Products: